KRAS+ NSCLC
Advertisement
A team integrating clinical, dual-energy spectral computed tomography, and radiomics features into a predictive model.
Glecirasib, also known as JAB-21822, is an oral, covalent KRAS G12C inhibitor.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.